NCT02103309

Brief Summary

The purpose of this study is to evaluate lens centration and subjective impressions of DAILIES® AquaComfort Plus® (DACP) lenses compared to 1-DAY ACUVUE® MOIST® (1DAM) lenses in ball sports players.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
42

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Oct 2013

Shorter than P25 for not_applicable

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2013

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2013

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2013

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

April 1, 2014

Completed
2 days until next milestone

First Posted

Study publicly available on registry

April 3, 2014

Completed
7 months until next milestone

Results Posted

Study results publicly available

October 29, 2014

Completed
Last Updated

October 29, 2014

Status Verified

October 1, 2014

Enrollment Period

1 month

First QC Date

April 1, 2014

Results QC Date

October 24, 2014

Last Update Submit

October 24, 2014

Conditions

Keywords

Soft contact lensesDACP

Outcome Measures

Primary Outcomes (1)

  • Mean Investigator-Rated Lens Centration

    Lens centration was assessed by the investigator using slit-lamp microscopy and rated on a 5-point scale, where 0=Optimal and 4=Severe decentration. Both eyes contributed to the mean.

    After 1 week of wear

Secondary Outcomes (3)

  • Mean Investigator-Rated Lens Fit

    After 1 week of wear

  • Average Subjective Ratings Score (Lens Handling and Overall Vision)

    After 1 week of wear

  • Average Subjective Ratings Score (Lens Wearing Conditions and Visual Performance During Ball Sports)

    After 1 week of wear

Study Arms (2)

DACP, then 1DAM

OTHER

Nelfilcon A contact lenses worn first, then etafilcon A contact lenses worn second. Each product worn bilaterally (in both eyes) for 1 week in a daily disposable mode.

Device: Nelfilcon A contact lensesDevice: Etafilcon A contact lenses

1DAM, then DACP

OTHER

Etafilcon A contact lenses worn first, then nelfilcon A contact lenses worn second. Each product worn bilaterally (in both eyes) for 1 week in a daily disposable mode.

Device: Nelfilcon A contact lensesDevice: Etafilcon A contact lenses

Interventions

Also known as: DAILIES® AquaComfort® Plus, DACP
1DAM, then DACPDACP, then 1DAM
Also known as: 1-DAY ACUVUE® MOIST®
1DAM, then DACPDACP, then 1DAM

Eligibility Criteria

Age18 Years - 29 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Those who can understand the clinical study objectives and provide written informed consent. Legal representative or parental consent required if under age 20
  • Those who regularly wear soft contact lenses in both eyes for a minimum of 8 hours per day and 5 days per week
  • Those who play ball sports at least 1 day per week
  • Those who need vision correction because of myopia or mild myopic astigmatism, who are eligible for use of the study device, and who can attain a visual acuity of at least 1.0 with correction

You may not qualify if:

  • Those who regularly wear the study device
  • Those who require ocular treatment with eye drops
  • Those who have a condition contraindicating soft contact lens wear, such as eye irritation
  • Those who have had ocular disorder or ocular surgery that may affect soft contact lens wear within 3 months before the start of the study
  • Those who are participating in another clinical study or research or have a plan of such participation during the present study
  • Women who are pregnant or intend to become pregnant during the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Refractive ErrorsMyopiaAstigmatism

Condition Hierarchy (Ancestors)

Eye Diseases

Results Point of Contact

Title
Director of Clinical Trials
Organization
Alcon Japan, Ltd.

Study Officials

  • Lisa L. Zoota, MPH, CCRA

    Alcon Research

    STUDY DIRECTOR

Publication Agreements

PI is Sponsor Employee
No
Restriction Type
OTHER
Restrictive Agreement
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 1, 2014

First Posted

April 3, 2014

Study Start

October 1, 2013

Primary Completion

November 1, 2013

Study Completion

November 1, 2013

Last Updated

October 29, 2014

Results First Posted

October 29, 2014

Record last verified: 2014-10